Portolan Capital Management, LLC Pulse Biosciences, Inc. Transaction History
Portolan Capital Management, LLC
- $1.6 Billion
- Q3 2025
A detailed history of Portolan Capital Management, LLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 102,197 shares of PLSE stock, worth $1.47 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
102,197Holding current value
$1.47 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
88Shares Held
5.76MCall Options Held
29.4KPut Options Held
24K-
Black Rock Inc. New York, NY1.15MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$16 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC805KShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$6.76 Million0.0% of portfolio
-
State Street Corp Boston, MA422KShares$6.08 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $535M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...